These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24532257)

  • 1. Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.
    Schilder JC; van Dijk JG; Dressler D; Koelman JH; Marinus J; van Hilten JJ
    J Neural Transm (Vienna); 2014 Jul; 121(7):761-7. PubMed ID: 24532257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Effect of Botulinum Toxin A Injections into the Extensor Digitorum Brevis Muscle after Local Mechanical Leg Vibration: A Case Report.
    Hefter H; Beek J; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jun; 13(6):. PubMed ID: 34203875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.
    Eleopra R; Tugnoli V; Rossetto O; De Grandis D; Montecucco C
    Neurosci Lett; 1998 Nov; 256(3):135-8. PubMed ID: 9855358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: a clinical and neurophysiological study.
    Gilio F; Iacovelli E; Frasca V; Gabriele M; Giacomelli E; Picchiori F; Soldo P; Cipriani AM; Ruoppolo G; Inghilleri M
    Amyotroph Lateral Scler; 2010 Aug; 11(4):359-63. PubMed ID: 19929745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve stimulation boosts botulinum toxin action in spasticity.
    Frasson E; Priori A; Ruzzante B; Didonè G; Bertolasi L
    Mov Disord; 2005 May; 20(5):624-9. PubMed ID: 15726575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No clinical or neurophysiological evidence of botulinum toxin diffusion to non-injected muscles in patients with hemifacial spasm.
    Lorenzano C; Bagnato S; Gilio F; Fabbrini G; Berardelli A
    Neurotox Res; 2006 Apr; 9(2-3):141-4. PubMed ID: 16785111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity.
    Conte A; Giannantoni A; Proietti S; Giovannozzi S; Fabbrini G; Rossi A; Porena M; Berardelli A
    Eur J Neurol; 2012 May; 19(5):725-32. PubMed ID: 22212295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral EMG Changes in Cervical Dystonia Patients and the Influence of Botulinum Toxin Treatment.
    Nijmeijer SWR; de Bruijn E; Verhagen R; Forbes PA; Kamphuis DJ; Happee R; Tijssen MAJ; Koelman JHTM
    Toxins (Basel); 2017 Aug; 9(9):. PubMed ID: 28832550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study.
    Siongco PRL; Rosales RL; Moore AP; Freynhagen R; Arimura K; Kanovsky P; Kaji R; Fernandez HH; Dressler D
    J Neural Transm (Vienna); 2020 Jun; 127(6):935-951. PubMed ID: 32146504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features.
    Yoshida K
    Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between botulinum neurotoxin type A2 and type A1 by electrophysiological study in healthy individuals.
    Mukai Y; Shimatani Y; Sako W; Asanuma K; Nodera H; Sakamoto T; Izumi Y; Kohda T; Kozaki S; Kaji R
    Toxicon; 2014 Apr; 81():32-6. PubMed ID: 24495439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional end-plate recovery in long-term botulinum toxin therapy of hemifacial spasm: a nerve conduction study.
    Butera C; Guerriero R; Amadio S; Ungaro D; Tesfaghebriel H; Bianchi F; Comi G; Del Carro U
    Neurol Sci; 2013 Feb; 34(2):209-15. PubMed ID: 22367224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin treatment of axial and cervical dystonia.
    Benecke R; Dressler D
    Disabil Rehabil; 2007 Dec; 29(23):1769-77. PubMed ID: 18033602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How effective is physical therapy for gait muscle activity in hemiparetic patients who receive botulinum toxin injections?
    Fujita K; Miaki H; Hori H; Kobayashi Y; Nakagawa T
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):8-18. PubMed ID: 29898587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical dystonia: clinical and therapeutic features in 85 patients.
    Camargo CH; Teive HA; Becker N; Baran MH; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2008 Mar; 66(1):15-21. PubMed ID: 18392407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
    Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
    Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type-A treatment in spastic paraparesis: a neurophysiological study.
    Pauri F; Boffa L; Cassetta E; Pasqualetti P; Rossini PM
    J Neurol Sci; 2000 Dec; 181(1-2):89-97. PubMed ID: 11099717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal motor cortex excitability during linguistic tasks in adductor-type spasmodic dysphonia.
    Suppa A; Marsili L; Giovannelli F; Di Stasio F; Rocchi L; Upadhyay N; Ruoppolo G; Cincotta M; Berardelli A
    Eur J Neurosci; 2015 Aug; 42(4):2051-60. PubMed ID: 26061279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.